What is Seaport Therapeutics 's shares (diluted)?

Seaport Therapeutics (SPTX) reported shares (diluted) of 2.5M in Q1 2026.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Seaport Therapeutics SPTX Shares (Diluted)

Shares (Diluted) at other companies

MYR GroupMYRG

15.7M-2.4%

RepligenRGEN

56.7M+0.2%

Silgan HoldingsSLGN

105.9M-1.4%

SezzleSEZL

34.9M-3.4%

Hancock Whitney CorporationHWC

82.3M-4.9%

SeaboardSEB

957.8K-1.4%

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's shares (diluted)?: Seaport Therapeutics (SPTX) reported shares (diluted) of 2.5M in Q1 2026.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.